{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:11:47Z","timestamp":1786302707472,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a high rate of mortality and recurrence. N6-methyladenosine methylation (m6A) is the most common modification to affect cancer development, but to date, the potential role of m6A regulators in ACC prognosis is not well understood. In this study, we systematically analyzed 21 m6A regulators in ACC samples from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. We identified three m6A modification patterns with different clinical outcomes and discovered a significant relationship between diverse m6A clusters and the tumor immune microenvironment (immune cell types and ESTIMATE algorithm). Additionally, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) revealed that the m6A clusters were strongly associated with immune infiltration in the ACC. Next, to further explore the m6A prognostic signatures in ACC, we implemented Lasso (Least Absolute Shrinkage and Selection Operator) Cox regression to establish an eight-m6A-regulator prognostic model in the TCGA dataset, and the results showed that the model-based high-risk group was closely correlated with poor overall survival (OS) compared with the low-risk group. Subsequently, we validated the key modifications in the GEO datasets and found that high HNRNPA2B1 expression resulted in poor OS and event-free survival (EFS) in ACC. Moreover, to further decipher the molecular mechanisms, we constructed a competing endogenous RNA (ceRNA) network based on HNRNPA2B1, which consists of 12 long noncoding RNAs (lncRNAs) and 1 microRNA (miRNA). In conclusion, our findings indicate the potential role of m6A modification in ACC, providing novel insights into ACC prognosis and guiding effective immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2021.637933","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T05:01:02Z","timestamp":1614747662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Yi","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.surg.2007.09.006","article-title":"Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma","volume":"142","author":"Gonzalez","year":"2007","journal-title":"Surgery."},{"key":"B4","first-page":"972","article-title":"Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery","volume":"112","author":"Icard","year":"1992","journal-title":"Surgery."},{"key":"B5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","author":"Assi\u00e9","year":"2019","journal-title":"JAMA Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"European Network for the Study of Adrenal, Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarc\u00f3n","year":"2015","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The critical role of RNA m6A methylation in cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m6A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m6A readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","article-title":"m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation","volume":"347","author":"Geula","year":"2015","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-methylation-dependent RNA processing controls the speed of the circadian clock","volume":"55","author":"Fustin","year":"2013","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","article-title":"RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response","volume":"543","author":"Xiang","year":"2017","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"m(6)A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.20892\/j.issn.2095-3941.2018.0365","article-title":"Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer","volume":"15","author":"Pinello","year":"2018","journal-title":"Cancer Biol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.3892\/ol.2018.9395","article-title":"Emerging function of N6-methyladenosine in cancer","volume":"16","author":"Hong","year":"2018","journal-title":"Oncol Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","article-title":"RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3","volume":"18","author":"Niu","year":"2019","journal-title":"Mol Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3389\/fcell.2020.00642","article-title":"N6-Methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients","volume":"8","author":"Tu","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1200\/JCO.19.01586","article-title":"PD-1 blockade in advanced adrenocortical carcinoma","volume":"38","author":"Raj","year":"2020","journal-title":"J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics."},{"key":"B29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Method."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"D226","DOI":"10.1093\/nar\/gkz793","article-title":"SNP2APA: a database for evaluating effects of genetic variants on alternative polyadenylation in human cancers","volume":"48","author":"Yang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/bioinformatics\/bts344","article-title":"miRcode: a map of putative microRNA target sites in the long non-coding transcriptome","volume":"28","author":"Jeggari","year":"2012","journal-title":"Bioinformatics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1053\/j.gastro.2018.08.030","article-title":"Association between expression level of PD1 by tumor-infiltrating CD8(+) T cells and features of hepatocellular carcinoma","volume":"155","author":"Kim","year":"2018","journal-title":"Gastroenterology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2017.02.006","article-title":"Inflammatory cytokines IL-17 and TNF-alpha up-regulate PD-L1 expression in human prostate and colon cancer cells","volume":"184","author":"Wang","year":"2017","journal-title":"Immunol Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.aau0447","article-title":"Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response","volume":"364","author":"Mandal","year":"2019","journal-title":"Science."},{"key":"B40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e000469","DOI":"10.1136\/jitc-2019-000469","article-title":"Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma","volume":"8","author":"Landwehr","year":"2020","journal-title":"J Immunother Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m(6)a-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell."},{"key":"B44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature14263","article-title":"Structural imprints in vivo decode RNA regulatory mechanisms","volume":"519","author":"Spitale","year":"2015","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.21037\/tlcr.2018.08.14","article-title":"Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians","volume":"7","author":"Allg\u00e4uer","year":"2018","journal-title":"Transl Lung Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12935-020-01309-5","article-title":"Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-014-0090-4","article-title":"Functions of lncRNA HOTAIR in lung cancer","volume":"7","author":"Loewen","year":"2014","journal-title":"J Hematol Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"29","author":"Rinn","year":"2007","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-kappaB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3390\/ijms20092279","article-title":"LncRNA HOTAIR in tumor microenvironment: what role?","volume":"20","author":"Botti","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cell.2013.03.025","article-title":"The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha","volume":"153","author":"Li","year":"2013","journal-title":"Cell."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.26355\/eurrev_201810_16139","article-title":"LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle","volume":"22","author":"Yan","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41419-019-1715-x","article-title":"miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/0008-5472.CAN-17-1318","article-title":"miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma","volume":"78","author":"D\u00edaz-Mart\u00ednez","year":"2018","journal-title":"Cancer Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.637933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T05:01:13Z","timestamp":1614747673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.637933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2021.637933"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.637933","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"article-number":"637933"}}